[go: up one dir, main page]

GB0318296D0 - A method of screening a sample - Google Patents

A method of screening a sample

Info

Publication number
GB0318296D0
GB0318296D0 GB0318296A GB0318296A GB0318296D0 GB 0318296 D0 GB0318296 D0 GB 0318296D0 GB 0318296 A GB0318296 A GB 0318296A GB 0318296 A GB0318296 A GB 0318296A GB 0318296 D0 GB0318296 D0 GB 0318296D0
Authority
GB
United Kingdom
Prior art keywords
screening
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0318296A
Other versions
GB2404734A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SECR DEFENCE
UK Secretary of State for Defence
Original Assignee
SECR DEFENCE
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE
Priority to GB0318296A priority Critical patent/GB2404734A/en
Publication of GB0318296D0 publication Critical patent/GB0318296D0/en
Priority to EP04743670A priority patent/EP1649291A1/en
Priority to CA002534815A priority patent/CA2534815A1/en
Priority to AU2004264053A priority patent/AU2004264053A1/en
Priority to PCT/GB2004/003385 priority patent/WO2005015240A1/en
Publication of GB2404734A publication Critical patent/GB2404734A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/746Erythropoetin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants
    • G01N2333/42Lectins, e.g. concanavalin, phytohaemagglutinin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/61Growth hormones [GH] (Somatotropin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
GB0318296A 2003-08-05 2003-08-05 A method of screening a sample for abnormally glycosylated and/or expressed proteins Withdrawn GB2404734A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0318296A GB2404734A (en) 2003-08-05 2003-08-05 A method of screening a sample for abnormally glycosylated and/or expressed proteins
EP04743670A EP1649291A1 (en) 2003-08-05 2004-08-05 Method for the detection of abnormally glycosylated proteins
CA002534815A CA2534815A1 (en) 2003-08-05 2004-08-05 Method for the detection of abnormally glycosylated proteins
AU2004264053A AU2004264053A1 (en) 2003-08-05 2004-08-05 Method for the detection of abnormally glycosylated proteins
PCT/GB2004/003385 WO2005015240A1 (en) 2003-08-05 2004-08-05 Method for the detection of abnormally glycosylated proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0318296A GB2404734A (en) 2003-08-05 2003-08-05 A method of screening a sample for abnormally glycosylated and/or expressed proteins

Publications (2)

Publication Number Publication Date
GB0318296D0 true GB0318296D0 (en) 2003-09-10
GB2404734A GB2404734A (en) 2005-02-09

Family

ID=27839646

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0318296A Withdrawn GB2404734A (en) 2003-08-05 2003-08-05 A method of screening a sample for abnormally glycosylated and/or expressed proteins

Country Status (5)

Country Link
EP (1) EP1649291A1 (en)
AU (1) AU2004264053A1 (en)
CA (1) CA2534815A1 (en)
GB (1) GB2404734A (en)
WO (1) WO2005015240A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1366364A4 (en) * 2001-03-07 2006-05-17 Bio Rad Laboratories Assay system for simultaneous detection and measurement of multiple modified cellular proteins
CN101487844B (en) * 2008-01-14 2013-03-27 开物科技股份有限公司 Electronic testing device and testing method
CA2764153C (en) 2009-06-02 2021-07-27 The Board Of Regents Of The University Of Texas System Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
EP2488543A1 (en) 2009-10-16 2012-08-22 The Board of Regents of The University of Texas System Compositions and methods for producing cyclic peptoid libraries
CN104678103A (en) * 2014-08-05 2015-06-03 首都医科大学附属北京佑安医院 Chemical luminescent protein chip, kit and detection method for detecting fucose index of seroglycoid
FI20155280A7 (en) 2015-04-15 2016-10-16 Medicortex Finland Oy Prognostic and diagnostic glycan-based biomarkers of brain damage
US20210311043A1 (en) * 2020-04-06 2021-10-07 Medicortex Finland Oy Method for determining a lectin-binding glycan indicative to traumatic brain injury

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939240A (en) * 1983-03-04 1990-07-03 Health Research, Inc. Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
JPH06105257B2 (en) * 1984-08-07 1994-12-21 協和メデックス株式会社 Cancer measurement kit
GB8726271D0 (en) * 1987-11-10 1987-12-16 Univ London Protein glycosylation assay
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
PT923730E (en) * 1996-09-06 2008-12-04 Univ Yale Prenatal screening for down`s syndrome using hyperglycosylated gonadotropin
AUPO943297A0 (en) * 1997-09-24 1997-10-16 University Of Melbourne, The Diagnostic test for alzheimer's disease
EP1366364A4 (en) * 2001-03-07 2006-05-17 Bio Rad Laboratories Assay system for simultaneous detection and measurement of multiple modified cellular proteins
EP1495323A2 (en) * 2002-04-05 2005-01-12 University Of Georgia Research Foundation, Inc. Method for cleaving and deglycosylating antibodies to promote ligand binding

Also Published As

Publication number Publication date
CA2534815A1 (en) 2005-02-17
WO2005015240A1 (en) 2005-02-17
EP1649291A1 (en) 2006-04-26
GB2404734A (en) 2005-02-09
AU2004264053A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
GB0309397D0 (en) Screening methods
GB2401328B (en) Screening apparatus
IL176376A0 (en) Method for analyzing a glycomolecule
EP1660671A4 (en) Methods for screening and identifying compounds
AU2003277663A1 (en) Screening method
GB0304993D0 (en) Novel screening method
GB0318296D0 (en) A method of screening a sample
GB0204387D0 (en) Screening process
GB0303936D0 (en) Method of testing
GB0308202D0 (en) A screening method using mass spectrometry
EP1721971A4 (en) Screening method
AU2003285503A1 (en) Screening method
EP1650562A4 (en) Method of screening useful protein
GB2399876B (en) Method of investigating a blood sample
AU2003202622A1 (en) A method of screening
GB0205755D0 (en) Screening method
GB0315971D0 (en) Screening apparatus and method
GB0225784D0 (en) Method of inspecting a sample
AU2003248955A8 (en) Screening method
GB0308890D0 (en) Screening method
GB0302700D0 (en) Screening method
GB0320771D0 (en) Method for screening
GB0226356D0 (en) Method of material analysis
GB0202921D0 (en) Screening method
GB0216960D0 (en) Screening method

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)